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Background: The aim of this study was to determine the osteoconductivity of biphasic calcium phosphate collagen
composite (BCPC) in rabbit calvarial defect model by comparing with biphasic calcium phosphate (BCP). Four 8 mm
diameter bicortical calvarial defects were made in ten rabbits. Each of the defects was randomly assigned and filled
with 1) collagen sponge, 2) BCP, 3) BCPC, and 4) nothing as control. The animals were sacrificed at either 2 weeks
(n = 5) or 8 weeks (n = 5) healing period.
Results: All groups showed wedge shaped new bone formation limited to the area of the defect margin at both
healing periods. The amounts of new bone and defect closure were similar among all groups. In the control and
collagen sponge group, the center of the defect was depressed by surrounding tissues. In contrast, in BCP and
BCPC group, the center of the defect did not depressed and the grafted materials maintained the space. And the
augmented area was significantly higher in BCP and BCPC group compared to the control and collagen sponge
group at both healing periods (p < 0.05).
Conclusions: The BCPC and BCP demonstrated proper space maintaining capacity and osteoconductive property,
suggesting BCPC can be efficiently utilized in various clinical situations.
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Various bone graft materials have been developed and
used for reconstruction of bony defects in periodontal
and implant surgeries. The autogenous bone is consid-
ered as the gold standard because of its superior capacity
in bone formation, however, has some clinical drawbacks
such as a morbidity of donor site and uncontrolled resorp-
tion rate [1,2]. Therefore, there have been many attempts
to develop bone graft materials which can replace and
substitute the autogenous bone.
Among various bone graft materials, calcium phosphate
(Ca-P) bone substitutes such as hydroxyapatite (HA) and
beta-tricalcium phosphate (β-TCP) have been widely used* Correspondence: shchoi726@yuhs.ac
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unless otherwise stated.because their chemical and structural characters are simi-
lar to those of human bone [1]. Indeed, they have shown
favorable biocompatibility and osteoconductivity when
used as bone graft materials [3]. Among Ca-Ps, HA, which
is very stable, can maintain the space effectively but has
low osteoconductivity [4,5]. In contrast, β-TCP is more
biodegradable and rapidly replaced by newly formed bone
but has low capacity of space maintaining [6]. Therefore
biphasic calcium phosphate (BCP), which is composed of
HA and β-TCP, was introduced to overcome limitations
of each material and several studies have been demon-
strated that BCPs can be used as bone substitutes suc-
cessfully [5,7,8].
Particle type BCPs have been frequently used and their
clinical efficacy was well-demonstrated. However, there
are some limitations on using particle type BCPs for bone
substitutes. Particle type BCPs are susceptible to externalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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be collapsed in non-contained defects [9]. Therefore, the
use of particle type BCPs may give technical difficulties to
clinicians in specific situations. Hence, block type BCPs
have been designed to impose stability in the defect of un-
favorable. However, the application of block type BCPs re-
quires adaptation, trimming and securement, which may
increase possibilities of surgical error. Moreover, bone in-
growth into the bone substitutes of block type depends
much upon its structural properties, and some studies re-
ported limited bone formation even though they were
used with osteoinductive materials [9,10].
Recently, BCP collagen composite (BCPC) graft materials
have been developed and explored as bone substitutes.
Due to excellent flexibility of the collagen, BCPC can
be easily molded into the desired shape while maintaining
the initial shape [11]. Moreover, collagen can promote
healing process by retaining blood clots and inducing
migration of fibroblasts [12]. Therefore BCPC can be
expected to have more favorable biological and mechan-
ical characteristics for bone formation and clinical hand-
ling, compared with above described BCPs. Thus, the aim
of this study was to determine the osteoconductivity of
BCPC in rabbit calvarial defect model by comparing with
BCP.Methods
Materials
The collagen sponges, BCP and BCPC were used as graft
materials in this study. The collagen sponges were made
of bovine type I collagen with cylinder form (8 mm
diameter and 2 mm vertical height). The BCP (Osteon™ II,
Genoss. Co. Ltd, Suwon, South Korea), a particle type graft
material, was composed of HA and β-TCP with the weight
ratio of 30/70. The sizes of particle and pore were 0.5 mm
to 1.0 mm and 250 μm respectively and the porosity was
70%. The BCPC (Osteon™ II collagen, Genoss. Co. Ltd,
Suwon, South Korea) was block type graft material with
cylinder form (8 mm diameter and 2 mm vertical height).
It was composed of BCP (Osteon™ II, Genoss. Co. Ltd,
Suwon, South Korea) and the bovine type I collagen and
the weight percentage of the collagen was 4%.Figure 1 Four circular defects with a diameter of 8 mm were
made in the rabbit calvarium and the experimental materials
were grafted as follows: (1) no graft, (2) Collagen sponge,
(3) BCP, (4) BCPC.Animals
Ten male New-Zealand white rabbits (mean body weight,
3.0 kg to 3.5 kg; 14 weeks to 16 weeks old) were used. All
animals were housed in separate cages with standard
laboratory conditions and fed with standard diets. All
of the procedures including animal selection, manage-
ment, preparation and surgical procedures followed
protocols approved by the Institutional Animal Care
and Use Committee, Yonsei Medical Center, Seoul, Korea
(approval number 2012–0031).Study design
In each rabbit calvarium, four circular bi-cortical defects
with a diameter of 8 mm were formed. And then, the de-
fects were randomly assigned to one of the following four
experimental groups and filled with each material (Figure 1).
The rabbits were allowed to get healing period of 2 weeks
(n = 5) or 8 weeks (n = 5).
 Control group: The defect was filled with blood clot
only.
 Collagen group: The collagen sponge was filled in the
defect.
 BCP group: BCP was filled in the defect.
 BCPC group: BCPC was filled in the defect.
Surgical procedure
The animals were intramuscularly injected and anesthe-
tized with a mixture of ketamine hydrochloride (Ketalar
VR, Yuhan Co, Seoul, Korea) and xylazine (Rumpun VR,
Bayer Korea Ltd, Seoul, Korea). After that, the surgical
sites were shaved and draped with povidone iodine and
alcohol followed by local anesthesia with 2% lidocaine.
An incision along the sagittal midline from frontal bone
to occipital bone was made and full thickness flap eleva-
tion was performed. Under the saline irrigation, four cir-
cular bi-cortical defects with a diameter of 8 mm were
made by using a trephine bur. Then, randomly assigned
graft materials were grafted into the defects. The flap was
sutured with a biodegradable suture material (Monosyn,
B-Braun, Melsungen, Germany) which was removed 10 days
later. Five animals were sacrificed at 2 and 8 weeks of post
surgery.
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Before embedding in paraffin blocks, all sections were
fixed using 10% buffered formalin solution (10% neutral
buffered formalin, BBC Biochemical, Mount Vernon, WA,
USA) and decalcified with 5% nitric acid (nitric acid,
Daejung Chemicals & Metals Co., Kyonggi, Korea). Then,
serial sectioning with 5 μm were performed along the
sagittal direction of the rabbit calvarium. Two sections
closest to the center of the defect were chosen and
stained with hematoxylin and eosin and Goldner’s Masson
trichrome.
Analysis methods
Clinical and histologic observations
For the clinical observation, animals were carefully ob-
served and evaluated for the presence of allergic reaction,
exposure of graft materials and inflammatory reaction
at 2 and 8 weeks after the surgery. For the histological
observation, a binocular microscope (Leica DM LB, Leica
Microsystems Ltd., Wetzlat, Germany) was used and all of
the specimens were examined by a single blinded examiner.
Histomorphometric observations
For evaluating the biodegradation and bone healing,
following four histomorphometric parameters were mea-
sured using an automated image-analysis system (Image-
Pro Plus, Media Cybernetics, Silver Spring, MD, USA)
(Figure 2).
1. New bone area: the area of newly formed bone in
the defect.
2. Defect closure: the ratio of the distance between the
newly formed bone over the initial distance between
the original defect margins.
3. Augmented area: the area between the defect margins
including bone tissues, marrow tissues, residual
materials, fibrovascular tissues and adipose tissues.
4. Residual material: the area of remaining grafted
materials in the defect.Figure 2 Schematic diagram of histomorphometric analysis.Statistical analysis
All values were presented as mean ± standard deviation
and a commercial software program (SPSS 21.0, SPSS Inc.,
Chicago, IL, USA) was used for the statistical analysis. For
multiple comparisons among the groups in a given time,
one-way ANOVA method test and Tukey-HSD post hoc
procedure were performed. Independent t-test was carried
out to analyze the statistical difference between 2 and
8 weeks healing period within each group.Results
Clinical findings
All experimental sites showed uneventful healing during
the postoperative healing period. Clinically, there was no
specific evidence of complications such as exposure of
graft materials.Histological findings
2 weeks healing period
All groups showed small amount of wedge shaped new
bone formation limited to the areas of the defect margin
and the amounts of newly formed bone seemed to be
similar among all groups. In the control and collagen
sponge group, the center of the defect was depressed
and flattened by surrounding connective tissue and dura
mater. In contrast, in BCP and BCPC group, the center
of the defect was not depressed and the grafted materials
maintained the space (Figure 3a, 3c, 3e, 3g).
On high magnification view, in the collagen sponge
group, the grafted collagen sponge was resorbed and
collapsed. In BCP and BCPC group, at the border of newly
formed bone, osteoblasts and osteoids were found in close
contact with BCP particles and inter-granular spaces were
mainly filled with loose connective tissue. The collagen
matrix of BCPC could not be clearly distinguished from
the inter-particular connective tissues of BCP (Figure 3b,
3d, 3f, 3h).
Figure 3 Histologictransversal sections obtained 2 weeks after surgery: (a, b) control group, (c, d) collagen sponge group, (e, f) BCP group,
(g, h) BCPC group. Arrowheads = defect margin; NB = new bone; G = graft material; C = connective tissue. (a, c, e, g) Goldner’s Masson trichrome
stain and original magnification: 40×; (b, d, f, h) Hematoxylin and eosin stain and original magnification: 200×.
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The histological findings of the control and collagen
sponge group were similar at 8 weeks healing period.
In the control and collagen sponge group, more newly
formed bone was found around the defect margin
compared to those of 2 weeks healing period. However,
the center of the defect was collapsed and mainly filled
with loose connective tissue. Among a few specimens,
the bony islands were found at the center of the defect
(Figure 4a, 4b, 4c, 4d). In BCP and BCPC group, the sizes
of BCP granules were similar between two groups, and re-
duced compared to those of 2 weeks healing period. The
space between defect margins was maintained by grafted
BCP particles. However, most of the newly formed bone
was limited to the defect margin, and loose connective tis-
sue and BCP particles occupied the space at the center of
the defect (Figure 4e, 4f, 4g, 4h).
Histomorphometric findings
The histomorphometric measurements are summarized
in Tables 1, 2, 3 and 4. There was no statistically significant
difference in new bone area and defect closure among allgroups during the same healing period. All of the groups,
except the collagen sponge group, showed statistically sig-
nificiant increase of new bone formation between 2 and
8 weeks healing period. In terms of defect closure, the
values significantly increased between 2 and 8 weeks heal-
ing periods in all of the groups (Tables 1, 2).
The augmented area was statistically greater in BCP and
BCPC group than those of the control and the collagen
sponge group at 2 and 8 weeks healing periods. There was
no statistically significant difference between 2 and 8 weeks
healing periods in the same experimental group (Table 3).
The amount of residual material was similar between
BCP and BCPC group at the same healing period and de-
creased between 2 and 8 weeks healing periods (Table 4).
Discussion
Biologically, the optimal bone substitutes must possess
biocompatibility, osteoconductivity, osteoinductivity and
similar structure to human bone. They should provide
structural framework for blood clot stabilization, maturation,
and replacement space for newly formed bone [2,13]. In a
clinical point of view, easy handling and cost-effectiveness
Figure 4 Histologictransversal sections obtained 8 weeks after surgery: (a, b) control group, (c, d) collagen sponge group, (e, f) BCP group,
(g, h) BCPC group. Arrowheads = defect margin; NB = new bone; G = graft material; C = connective tissue. (a, c, e, g) Goldner’s Masson trichrome
stain and original magnification: 40×; (b, d, f, h) Hematoxylin and eosin stain and original magnification: 200×.
Table 1 New bone area (mm2; Group Mean ± SD; n = 5)
2 weeks 8 weeks
Control 1.24 ± 0.35 3.29 ± 0.62#
Collagen 1.66 ± 0.85 2.43 ± 0.44
BCP 1.33 ± 0.49 2.47 ± 0.25#
BCPC 1.32 ± 0.56 2.41 ± 0.20#
There was no statistically significant difference among all groups in same
healing period.
#Significantly different from same experimental group at 2 weeks.
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performed in a pursuit of both respects.
In the present study, we evaluated the osteoconductiv-
ity of BCPC in the rabbit calvarial defect. Nowadays the
addition of collagen to bone substitute is expected to give
benefits in bone regenerative therapy of dental field, on
which many studies are focused. Collagen, which is one of
the major organic components of human bone, has sev-
eral advantageous properties for bone healing including
hemostasis, chemotactic activity to attract fibroblast, and
promotion of wound stabilization [14-16]. Moreover, it
has been proven that collagen regulates gene expression
and differentiation of osteoclasts [17]. Nonetheless, colla-
gen itself has a major drawback as a bone substitute due
to fast resorption by the activity of macrophages, leuko-
cytes and bacteria, resulting in failure of space mainten-
ance for new bone in-growth [15,18].
However, addition of collagen to bone substitute may
compensate for the weaknesses of conventional bone sub-
stitutes. Particle type BCPs has been used in many studies
and demonstrated space maintaining capacity and bone
regenerative potential [8,19,20], but the performanceof BCP on bone regeneration may be compromised in
non-contained defects [9]. Block type BCP may be ad-
vantageous to overcome unfavorable defects, but its
application may entail surgical difficulty and its three-
dimensional microstructure may not be appropriate for
bone in-growth [9,10]. With combination of BCP and
collagen, BCP particles can provide volume stability and
collagen matrix can promote cell proliferation and infiltra-
tion of osteoblasts [21].
Rabbit calvarial defect models have been used widely for
evaluating newly developed bone substitutes because of
adequate quantity and quality of bone marrow [22]. The
Table 4 Residual material (mm2; Group Mean ± SD; n = 5)
2 weeks 8 weeks
Collagen 0 0
BCP 3.89 ± 0.83 2.66 ± 0.43#
BCPC 4.24 ± 0.41 2.09 ± 0.63#
#Significantly different from same experimental group at 2 weeks.
Table 2 Defect closure (%; Group Mean ± SD; n = 5)
2 weeks 8 weeks
Control 29.25 ± 4.61 54.76 ± 7.44#
Collagen 29.84 ± 5.97 48.78 ± 6.96#
BCP 26.29 ± 5.73 50.95 ± 3.66#
BCPC 26.52 ± 4.64 45.75 ± 11.62#
There was no statistically significant difference among all groups in same
healing period.
#Significantly different from same experimental group at 2 weeks.
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as 10–15 mm through several studies [23-25]. Although
8 mm diameter rabbit calvarial defect is smaller than crit-
ical one, it has been known to be useful to evaluate defect
healing pattern and bone regeneration [26,27]. And it
has been proven that 8 mm circular defects in rabbit
calvarium show limited bone healing within 8 weeks
healing period in several studies [28,29]. Therefore, in this
study, four 8 mm circular defects were made in the rabbit
calvarium and bone healing was evaluated at 2 and 8 weeks
after surgery, respectively. There could be a concern that
extravasation of experimental materials from neighboring
defects affected the results. However, the type of defect
used in this study was contained. And no graft materials
from another defect were found in the control site. There-
fore the effect of neighboring defects can be thought to be
minimal.
In histologic and histomorphmetric analysis, collagen
sponge was totally resorbed and collapsed within 2 weeks
healing period and showed similar healing pattern to
control group. However, BCP and BCPC showed relatively
slow resorption and maintained the space effectively, which
is consistent with other previous studies [30,31]. This
result suggests that both BCP and BCPC have favorable
space maintaining capacity. The maintenance of the
space for bone in-growth is important to stabilize blood
clots and prevent downward growth of epithelium
[32,33].
The amount of new bone and defect closure increased
throughout the healing period in all groups. And there
was no statistically significant difference among all groups
at 2 and 8 weeks healing periods. Although BCP graft
materials are commonly used as bone substitutes, the
capacity of new bone formation of BCPs remainsTable 3 Augmented area (mm2; Group Mean ± SD; n = 5)
2 weeks 8 weeks
Control 4.37 ± 0.65 8.00 ± 0.79
Collagen 5.06 ± 2.34 5.59 ± 0.84
BCP 12.88 ± 2.45# 14.23 ± 0.71#
BCPC 14.35 ± 0.91# 12.92 ± 2.56#
#Significantly different from control and collagen group in same
healing period.controversial. Numerous studies have demonstrated en-
hanced bone formation when BCPs were grafted in vari-
ous defect models [7,29,30]. Whereas, some studies
reported that grafted BCPs did not induce increased bone
formation, which coincides with this study [31,34]. There-
fore recent studies have tried to enhance the osteogenic
capacity of BCP graft materials using osteoinductive mate-
rials such as BMPs [10,35]. Although increased new bone
formation did not occur in this study, new bone was found
in close contact with BCP particles in BCP and BCPC
group with high magnification observation. This means
that both BCP and BCPC are biocompatible and have
good osteoconductive properties.
In this study, BCP and BCPC exhibited similar healing
and bone regeneration pattern in total amount of new
bone and augmented area. Both materials could be used as
promising bone substitutes successfully. Further studies
should be carried out to confirm that BCPC has advan-
tages over BCP in the healing of non-contained type
defects.
Collagen which is a component of BCPC has been widely
used as a carrier of bioactive materials [36]. In a previous
study, it has been shown that BCPC can be soaked with
growth factors easily [37]. Therefore, BCPC could be also
used as a promising carrier when bony defects are large or
non-contained form where space maintenance becomes
highly important.Conclusions
In conclusion, the BCPC and BCP demonstrated proper
space maintaining capacity and osteoconductive property,
suggesting BCPC can be efficiently utilized in various clin-
ical situations.Availability of supporting data
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